COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
journal contribution
submitted on 2023-03-15, 08:00 and posted on 2023-03-16, 06:18 authored by Lina Okar, Mohammad Ali, Jabeed Parengal, Mohamed A. YassinAlthough the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: http://dx.doi.org/10.1002/ccr3.3345
History
Language
- English
Publisher
WileyPublication Year
- 2020
Institution affiliated with
- Hamad Medical Corporation
- National Center for Cancer Care and Research (Hamad Medical Corporation)
